Cargando…

Mylotarg has potent anti-leukaemic effect: a systematic review and meta-analysis of anti-CD33 antibody treatment in acute myeloid leukaemia

Conventional chemotherapy is ineffective in the majority of patients with acute myeloid leukaemia (AML), and monoclonal antibodies recognising CD33 expressed on myeloid progenitors (e.g. gemtuzumab ozogamicin (GO)) have been reported to improve outcome in patients with AML. Reports of excess toxicit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Loke, J., Khan, J. N., Wilson, J. S., Craddock, C., Wheatley, K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317519/ https://www.ncbi.nlm.nih.gov/pubmed/25284166 http://dx.doi.org/10.1007/s00277-014-2218-6

Ejemplares similares

Efficacy and tolerability of gemtuzumab ozogamicin (anti-CD33 monoclonal antibody, CMA-676, Mylotarg(®)) in children with relapsed/refractory myeloid leukemia
por: Brethon, Benoit, et al.
Publicado: (2006)

Targeting of CD34(+)CD38(-) cells using Gemtuzumab ozogamicin (Mylotarg) in combination with tipifarnib (Zarnestra) in acute Myeloid Leukaemia
por: Jawad, Mays, et al.
Publicado: (2012)

Isolated CNS leukaemic relapse in acute myeloid leukaemia
por: Essa, Amr, et al.
Publicado: (2019)

The impact of At1r inhibition via losartan on the anti-leukaemic effects of doxorubicin in acute myeloid leukaemia
por: Ghasemi, Mehdi, et al.
Publicado: (2019)

Classic and targeted anti‐leukaemic agents interfere with the cholesterol biogenesis metagene in acute myeloid leukaemia: Therapeutic implications
por: Chen, Fangli, et al.
Publicado: (2020)

In vitro generation of lymphocytotoxicity to autochthonous leukaemic cells in chronic myeloid leukaemia.
por: Khare, A. G., et al.
Publicado: (1981)

Cellular sensitization in chronic myeloid leukaemia patients to leukaemic blast antigens.
por: Gangal, S. G., et al.
Publicado: (1979)

miR-22 has a potent anti-tumour role with therapeutic potential in acute myeloid leukaemia
por: Jiang, Xi, et al.
Publicado: (2016)

DNA-PK Inhibitor, M3814, as a New Combination Partner of Mylotarg in the Treatment of Acute Myeloid Leukemia
por: Carr, Michael I., et al.
Publicado: (2020)

The in vitro activity of the tyrosine kinase inhibitor STI571 in BCR–ABL positive chronic myeloid leukaemia cells: synergistic interactions with anti-leukaemic agents
por: Liu, W M, et al.
Publicado: (2002)

Cytogenetic analysis of leukaemic colonies from acute and chronic myelogenous leukaemia.
por: Trent, J. M., et al.
Publicado: (1983)

Leukaemic pleural effusion as a manifestation of acute myeloid leukaemia: a case report and review of literature
por: Duhan, Amrita, et al.
Publicado: (2014)

P471: POLO-LIKE KINASE 4 INHIBITION INDUCED ANTI-LEUKAEMIC EFFECTS THROUGH HISTONE MODIFICATION IN TP53 MUTATED ACUTE MYELOID LEUKAEMIA
por: Lam, Wing, et al.
Publicado: (2023)

FLT3 inhibitors in acute myeloid leukaemia: assessment of clinical effectiveness, adverse events and future research—a systematic review and meta-analysis
por: Majothi, S., et al.
Publicado: (2020)

The role of allogeneic stem cell transplantation in the management of acute myeloid leukaemia: a triumph of hope and experience
por: Loke, Justin, et al.
Publicado: (2019)

Studies on Mouse Leukaemia. The Role of the Thymus in Leukaemogenesis by Cell-free Leukaemic Filtrates
por: Miller, J. F. A. P.
Publicado: (1960)

Leukaemic infiltration of gall bladder – unusual presentation of occult chronic lymphocytic leukaemia
por: Rao, VSR, et al.
Publicado: (2011)

Acute Renal Failure due to Leukaemic Infiltration in Chronic Lymphocytic Leukaemia
por: Kayar, Yusuf, et al.
Publicado: (2015)

Receptors for human immunoglobulin on acute myeloid leukaemic leucocytes.
por: Ridway, J. C., et al.
Publicado: (1976)

The Effect of Tissue Oxygen Tension on the Radiosensitivity of Leukaemia Cells Irradiated In Situ in the Livers of Leukaemic Mice
por: Hewitt, H. B., et al.
Publicado: (1959)

Electrostatic anti-CD33-antibody–protamine nanocarriers as platform for a targeted treatment of acute myeloid leukemia
por: Bäumer, Nicole, et al.
Publicado: (2022)

The combination of histone deacetylase inhibitors with immune-stimulating antibodies has potent anti-cancer effects
por: West, Alison C., et al.
Publicado: (2012)

Human myeloid leukaemic cell interactions in vitro with normal myeloid colonies.
por: Spitzer, G., et al.
Publicado: (1981)

Generation of Leukaemia-Derived Dendritic Cells (DC(leu)) to Improve Anti-Leukaemic Activity in AML: Selection of the Most Efficient Response Modifier Combinations
por: Schwepcke, Christoph, et al.
Publicado: (2022)

Leukaemic Ascites and Peritoneal Myeloid Sarcoma: Rare but Not Impossible
por: Landeiro, Luís, et al.
Publicado: (2022)

Divergent Autologous T Cell Responses to Leukaemic Dendritic Cells during Remission in Acute Promyelocytic Leukaemia
por: Westers, Theresia M., et al.
Publicado: (2005)

CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity
por: Jacoby, Elad, et al.
Publicado: (2016)

JC and BK virus sequences are not detectable in leukaemic samples from children with common acute lymphoblastic leukaemia
por: MacKenzie, J, et al.
Publicado: (1999)

Diffuse Large B-Cell Lymphoma Relapsing in Leukaemic Phase Presenting as Acute Leukaemia
por: Balasubramanian, Priyavadhana, et al.
Publicado: (2019)

Anti-Leukaemic Activity of Rilpivirine Is Mediated by Aurora A Kinase Inhibition
por: Islam, Saiful, et al.
Publicado: (2023)

In Vitro and In Vivo Antitumor Effect of Anti-CD33 Chimeric Receptor-Expressing EBV-CTL against CD33(+) Acute Myeloid Leukemia
por: Dutour, A., et al.
Publicado: (2012)

Effects of varying the interval between courses of methotrexate on its myelotoxic and anti-leukaemic activities.
por: Harding, B., et al.
Publicado: (1977)

Novel anti-CD30/CD3 bispecific antibodies activate human T cells and mediate potent anti-tumor activity
por: Faber, Mary L., et al.
Publicado: (2023)

A Single Domain–Based Anti-Her2 Antibody Has Potent Antitumor Activities
por: Wu, Xiaoqiong, et al.
Publicado: (2018)

Pseudo-Leukæmic Lymphosarcoma
por: Ainley, Norman J.
Publicado: (1949)

Quantitative determination of mdr1 gene expression in leukaemic cells from patients with acute leukaemia.
por: Gruber, A., et al.
Publicado: (1992)

Covert pre-leukaemic clones in healthy co-twins of patients with childhood acute lymphoblastic leukaemia
por: Ford, Anthony M., et al.
Publicado: (2022)

Structural and Functional Characterization of Anti-A33 Antibodies Reveal a Potent Cross-Species Orthopoxviruses Neutralizer
por: Matho, Michael H., et al.
Publicado: (2015)

BCP-ALL blasts are not dependent on CD19 expression for leukaemic maintenance
por: Weiland, J, et al.
Publicado: (2016)

The return of gemtuzumab ozogamicin: a humanized anti-CD33 monoclonal antibody–drug conjugate for the treatment of newly diagnosed acute myeloid leukemia
por: Egan, Pamela C, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_kptup851d21fnf4n7or5gn965h